Chemed Corporation Board of Directors Authorizes an Additional $300 Million for Stock Repurchase and Declares Quarterly Dividend of 50 Cents

CHE 11.08.2024

Full Press ReleaseSEC FilingsOur CHE Tweets

About Gravity Analytica

Recent News

  • 01.14.2025 - 43rd Annual JPMorgan Healthcare Conference
  • 01.07.2025 - Chemed Corporation to Present at the 43rd Annual JPMorgan Healthcare Conference
  • 12.10.2024 - BofA Securities 2024 Virtual Home Care Conference

Recent Filings

  • 12.30.2024 - 4 Statement of changes in beneficial ownership of securities
  • 11.25.2024 - 144 Report of proposed sale of securities
  • 11.01.2024 - 10-Q Quarterly report [Sections 13 or 15(d)]
PDF Version

CINCINNATI--(BUSINESS WIRE)--Nov. 8, 2024--Chemed Corporation(NYSE:CHE) announced today that the Board of Directors has formally authorized an additional$300 millionfor stock repurchase under Chemed’s existing share repurchase program. These share repurchases will be funded through a combination of cash generated from operations as well as utilization of its revolving credit facility.

The Board of Directors has declared a quarterly cash dividend of50-centsper share on the Company’s capital stock, payable onDecember 6, 2024, to shareholders of record as ofNovember 18, 2024. This is equal to the dividend paid inAugust 2024. This represents the 214thconsecutive quarterly dividend paid by Chemed in its 53 years as a public company.

Listed on theNew York Stock Exchangeand headquartered inCincinnati, Ohio,Chemed Corporation(www.chemed.com) operates two wholly owned subsidiaries:VITAS HealthcareandRoto-Rooter. VITAS is the nation's largest provider of end-of-life hospice care andRoto-Rooteris the nation’s leading provider of plumbing and drain cleaning services.

Statements in this press release or in other Chemed communications may relate to future events or Chemed's future performance. Such statements are forward-looking statements and are based on present information Chemed has related to its existing business circumstances. Investors are cautioned that such forward-looking statements are subject to inherent risk that actual results may differ materially from such forward-looking statements. Further, investors are cautioned that Chemed does not assume any obligation to update forward-looking statements based on unanticipated events or changed expectations.

View source version onbusinesswire.com:https://www.businesswire.com/news/home/20241107809611/en/

Michael D. Witzeman(513) 762-6714

Source:Chemed Corporation

Please be aware that the following content has been generated by an AI system and may contain errors, inconsistencies, or outdated information. It is provided as-is without any warranties or guarantees of accuracy. We strongly recommend using this content as a starting point for further research and consultation with relevant experts or authorities. We disclaim any liability for damages or losses resulting from the use or reliance on this content.Please note that this is a beta version of the Gravity Analytica LLC’s AI Service which isstill undergoing final testing before its official release. Theplatform, its software and all content found on it are provided on an“as is” and “as available” basis. Gravity Analytica LLC does not give any warranties,whether express or implied, as to the suitability or usability of thisservice, webpage, or its software or any of its content.Should you encounter any bugs, glitches, lack of functionality orother problems on the website, please let us know immediately so wecan rectify these accordingly. Your help in this regard is greatlyappreciated! You can write to us at this addressteam@gravityanalytica.com